You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 359 Developing human placental CD34-derived natural killer cells with high affinity and cleavage resistant CD16 and secreted IL-15 (CYNK-201) for cancer immunotherapy

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
359 Developing human placental CD34-derived natural killer cells with high affinity and cleavage resistant CD16 and secreted IL-15 (CYNK-201) for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: November 2023 to September 2024

AbstractFullPdf
Nov 2023292017
Dec 20238307
Jan 20244602
Feb 20242402
Mar 20243800
Apr 20246205
May 20243002
Jun 20242806
Jul 20242801
Aug 20242700
Sep 20242401
Total682043